Is ultrasound alone enough for prenatal screening of trisomy 18? A single centre experience in 69 cases over 10 years

AbstractObjectivesTo evaluate ultrasound scan and other prenatal screening tests for trisomy 18 in a regional obstetric unit and to review the management approach for women with positive trisomy 18 screening results.MethodsPrenatal diagnosis databases were accessed to identify fetuses that had confirmed trisomy 18 karyotypes or were at high risk for trisomy 18 on second‐trimester biochemical screening or first‐trimester combined screening tests over a period of 10 years from 1 September 1997 to 30 September 2007.ResultsSixty‐nine women were confirmed to have trisomy 18 fetuses by karyotyping either prenatally (n = 61) or postnatally/post‐miscarriage (n = 8) during the study period. The detection rate of ultrasound scan ≤14 weeks and 18 to 21 weeks to detect trisomy 18 was 92.7 and 100%, respectively. A total of 80 and 87% of fetuses had two or more ultrasound abnormalities detected in the ≤14 weeks and 18 to 21 weeks anomaly scans, respectively. Forty‐eight women screened positive for trisomy 18 by second‐trimester biochemical screening with human chorionic gonadotrophin (hCG) and alpha fetoprotein (AFP). Only one was true positive (positive predictive value = 1/48 or 2%). Eleven women screened positive for trisomy 18 by first‐trimester combined screening with nuchal translucency scan and maternal serum for pregnancy‐associated plasma protein A (PAPP‐A) and hCG between 11 and 13 + 6 weeks. Three were true positive (positive predictive value = 3/11 or 27%). All four cases with positive screening had ultrasound abnormalities.ConclusionsUltrasound scan for fetal anomalies is the most effective screening test for trisomy 18. A policy of conservative management for women with positive second‐trimester biochemical screening or first‐trimester combined screening for trisomy 18 is reasonable in the absence of ultrasound fetal abnormalities. Unnecessary invasive tests can be avoided. Copyright © 2010 John Wiley & Sons, Ltd.